The world's first AI-based early lung cancer decision support software
Our platform helps clinicians to identify and track at-risk patients and make optimal clinical management decisions.
WHAT WE DO
We are a lung health company,
developing products to help clinicians in the management, diagnosis and care of patients.
WHO WE ARE
A team of award-winning machine learning, medical device and clinical experts who work with top hospitals, physicians and authors of lung cancer guidelines across Europe and US.
HOW WE CAN
Optellum has gathered the largest real-world dataset of CT scans and, using Artificial Intelligence and Machine Learning, developed a solution to enable clinicians to identify at-risk patients and to guide lung cancer management.
Latest News and events
Optellum in the news
PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology
Patients and physicians benefit from Optellum’s Virtual Nodule Clinic
Optellum’s AI could speed up lung cancer screening by detecting benign perifissural lung nodules